Comment in Nature Reviews on Repurposing

Pantziarka, P. (2017). Scientific advice — is drug repurposing missing a trick? Nature Reviews Clinical Oncology, 14(8), 455–456. doi:10.1038/nrclinonc.2017.69

Annual Impact Sheet 2016

Policy paper on Repurposing

On paranoid parents.

Pantziarka, P. (2017). On paranoid parents. Pediatric Blood & Cancer, 64(7). doi:10.1002/pbc.26440

Guide on non-conventional treatment options in breast cancer

ReDO: propranolol as an anti-cancer agent

Pantziarka, P., Bouche, G., Sukhatme, V., Meheus, L., Rooman, I., & Sukhatme, V. P. (2016). Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent. Ecancermedicalscience, 10, 680. doi:10.3332/ecancer.2016.680

ReDO: diclofenac as an anti-cancer agent

Pantziarka, P., Sukhatme, V., Bouche, G., Meheus, L., & Sukhatme, V. P. (2016). Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience, 10, 610. doi:10.3332/ecancer.2016.610

Patient and health systems opportunities

Bertolini, F., Sukhatme, V.P., & Bouche, G. (2015). Drug repurposing in oncology—patient and health systems opportunities. Nature Reviews Clinical Oncology, 12(12):732-42. doi:10.1038/nrclinonc.2015.169